1. Britton RC, Habif DV (1953). Clinical uses of hyaluronidase: a current review. Surgery 33:917?942
2. Depierre A, Lemarie E, Dabouis G, Samak R, Krikorian A, Besenval M (1988) Phase II study of navelbine (NVB) in non small cell lung cancer (NSCLC) (abstract). Proc Am Soc Clin Oncol 7:778
3. Dorr RT (1990) Antidotes to vescicant chemotherapy extravasations. Blood Rev 4:41?60
4. Dorr RT, Alberts DS (1985)Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse. J Natl Cancer Inst 74:113?120
5. Schneider SM, Distelhorst CW (1989) Chemotherapy-induced emergencies. Semin Oncol 16:572?578